HALOZYME THERAPEUTICS INC (16) | Business Finance (12)

Browse by Subcategory

Recent Contracts

Halozyme Therapeutics, Inc. 2021 Stock Plan (Filed With SEC on May 5, 2021)
Indenture, dated March 1, 2021 between Halozyme Therapeutics, Inc. and The Bank of New York Mellon Trust Company, N.A., as trustee (Filed With SEC on March 1, 2021)
Form of Note, dated March 1, 2021 between Halozyme Therapeutics, Inc. and The Bank of New York Mellon Trust Company, N.A., as trustee (Filed With SEC on March 1, 2021)
Third Amendment to Loan and Security Agreement between Oxford, SVB and Registrant, dated June 14, 2019 (Filed With SEC on August 6, 2019)
Halozyme Therapeutics, Inc. 2021 Employee Stock Purchase Plan (Filed With SEC on May 5, 2021)
Form of Stock Option Agreement (2021 Stock Plan) (Filed With SEC on May 5, 2021)
Form of Restricted Stock Units Agreement for Officers (2021 Stock Plan) (Filed With SEC on May 5, 2021)
Form of Restricted Stock Units Agreement (2021 Stock Plan) (Filed With SEC on May 5, 2021)
Form of Restricted Stock Award Agreement (2021 Stock Plan) (Filed With SEC on May 5, 2021)
Form of Director Restricted Stock Units Agreement (2021 Stock Plan) (Filed With SEC on May 5, 2021)
Form of Note, dated November 18, 2019 between Halozyme Therapeutics, Inc. and The Bank of New York Mellon Trust Company, N.A, as trustee (Filed With SEC on November 18, 2019)
Indenture, dated November 18, 2019 between Halozyme Therapeutics, Inc. and The Bank of New York Mellon Trust Company, N.A, as trustee (Filed With SEC on November 18, 2019)